Anti-NKG2C/ KLRC2/ CD159c monoclonal antibody
Anti-NKG2C/ KLRC2/ CD159c antibody for FACS & in-vivo assay
Go to KLRC2/KLRC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0711-Ab-1/ GM-Tg-hg-MP0711-Ab-2 | Anti-Human KLRC2 monoclonal antibody | Human |
GM-Tg-rg-MP0711-Ab-1/ GM-Tg-rg-MP0711-Ab-2 | Anti-Rat KLRC2 monoclonal antibody | Rat |
GM-Tg-mg-MP0711-Ab-1/ GM-Tg-mg-MP0711-Ab-2 | Anti-Mouse KLRC2 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0711-Ab-1/ GM-Tg-cynog-MP0711-Ab-2 | Anti-Cynomolgus/ Rhesus macaque KLRC2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0711-Ab-1/ GM-Tg-felg-MP0711-Ab-2 | Anti-Feline KLRC2 monoclonal antibody | Feline |
GM-Tg-cang-MP0711-Ab-1/ GM-Tg-cang-MP0711-Ab-2 | Anti-Canine KLRC2 monoclonal antibody | Canine |
GM-Tg-bovg-MP0711-Ab-1/ GM-Tg-bovg-MP0711-Ab-2 | Anti-Bovine KLRC2 monoclonal antibody | Bovine |
GM-Tg-equg-MP0711-Ab-1/ GM-Tg-equg-MP0711-Ab-2 | Anti-Equine KLRC2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0711-Ab-1/ GM-Tg-hg-MP0711-Ab-2; GM-Tg-rg-MP0711-Ab-1/ GM-Tg-rg-MP0711-Ab-2; GM-Tg-mg-MP0711-Ab-1/ GM-Tg-mg-MP0711-Ab-2; GM-Tg-cynog-MP0711-Ab-1/ GM-Tg-cynog-MP0711-Ab-2; GM-Tg-felg-MP0711-Ab-1/ GM-Tg-felg-MP0711-Ab-2; GM-Tg-cang-MP0711-Ab-1/ GM-Tg-cang-MP0711-Ab-2; GM-Tg-bovg-MP0711-Ab-1/ GM-Tg-bovg-MP0711-Ab-2; GM-Tg-equg-MP0711-Ab-1/ GM-Tg-equg-MP0711-Ab-2 |
Products Name | Anti-KLRC2 monoclonal antibody |
Format | mab |
Target Name | KLRC2 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-KLRC2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species NKG2C/ KLRC2/ CD159c VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | vGMLP004493 | human KLRC2 Lentivirus particle |
ORF Viral Vector | pGMLP004493 | human KLRC2 Lentivirus plasmid |
ORF Viral Vector | pGMLPm004505 | mouse Klrc2 Lentivirus plasmid |
ORF Viral Vector | vGMLPm004505 | mouse Klrc2 Lentivirus particle |
Target information
Target ID | GM-MP0711 |
Target Name | KLRC2 |
Gene ID | 3822,114670780 |
Gene Symbol and Synonyms | CD159c,KLRC2,NKG2-C,NKG2C |
Uniprot Accession | P26717 |
Uniprot Entry Name | NKG2C_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000205809 |
Target Classification | N/A |
The target: KLRC2, gene name: KLRC2, also named as CD159c, NKG2-C, NKG2C. Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. The group, designated KLRC (NKG2) are expressed primarily in natural killer (NK) cells and encodes a family of transmembrane proteins characterized by a type II membrane orientation (extracellular C terminus) and the presence of a C-type lectin domain. The KLRC (NKG2) gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed on NK cells. KLRC2 alternative splice variants have been described but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.